Publications by authors named "E Marion"
The Duke University Clinical and Translational Science Institute Community Engaged Research Initiative (CERI) created an e-Library in 2018. This e-Library was developed in response to requests from academic researchers and the community for reliable, easily accessible information about community-engaged research approaches and concepts. It was vetted by internal and external partners.
View Article and Find Full Text PDFArticle Synopsis
- - The study investigates the relationship between neighborhood socioeconomic status (SES) and the likelihood of ongoing pregnancies after 2.5 years of IVF treatment among 2,669 couples.
- - Researchers categorized SES into low, medium, and high based on postal codes and found significant differences in ongoing pregnancy rates, with lower rates in low SES neighborhoods.
- - The results indicated that couples from low SES areas had 34% lower odds of achieving ongoing pregnancies within the studied timeframe compared to those from high SES areas.
We identified a high prevalence (46.4%) of wound colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients hospitalized in a center devoted to the treatment of cutaneous tropical diseases in Benin. The proportion of MRSA among S aureus isolates was 54.
View Article and Find Full Text PDFUnlabelled: The classical lineage of is the most prevalent clonal group associated with Buruli ulcer in humans. Its reservoir is strongly associated with the environment. We analyzed together 1,045 isolates collected from 13 countries on two continents to define the evolutionary history and population dynamics of this lineage.
View Article and Find Full Text PDFImproving the quality and conduct of multi-center clinical trials is essential to the generation of generalizable knowledge about the safety and efficacy of healthcare treatments. Despite significant effort and expense, many clinical trials are unsuccessful. The National Center for Advancing Translational Science launched the Trial Innovation Network to address critical roadblocks in multi-center trials by leveraging existing infrastructure and developing operational innovations.
View Article and Find Full Text PDF